Healthscope Limited confirmed on Thursday it has received a revised takeover offer from a private equity group at $5.75 per share, originally priced at $5.50 per share.

The new offer values the private hospital and pathology provider at $1.82 billion.

A statement released today by Healthscope stated that its board of directors and its advisers carefully reviewed the previous proposal from the private equity group, and it was given the chance to revise its proposal.

Healthscope said the new proposal is now subject to review by the board.

The company said it advises its shareholders to take no further action and must wait for announcements once decisions have been made.

Healthscope also assured that it is performing well and has delivered an outstanding annual growth in total shareholder returns of 58 per cent over the past 10 years.

"The board believes that the company is well positioned to continue to deliver strong growth," Healthscope said.

The company will also push for additional facilities such as beds and theatres at existing hopsitals and will implement the leverage volumes and increase bed occupancy.

Healthscope said it has a good position to lift market share in pathology.

Healthscope's shares last traded at %.18.